This inventor holds 2 USPTO granted patents and 10 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2024-2025.
Company Filing History:
Years Active: 2024-2025
Title: Joseph Daniel Szustakowski: Innovator in Tumor Treatment
Introduction
Joseph Daniel Szustakowski is a notable inventor based in Pennington, NJ (US). He has made significant contributions to the field of cancer treatment, particularly in addressing small cell lung cancer (SCLC). His innovative approach focuses on utilizing specific antibodies to enhance treatment efficacy for patients with high tumor mutational burden (TMB) status.
Latest Patents
Joseph Szustakowski holds 1 patent for his work titled "Methods of treating tumor." This patent outlines a method for treating subjects afflicted with tumors derived from SCLC. The method involves administering a monotherapy comprising an anti-PD-1 antibody or a combination therapy that includes both an anti-PD-1 antibody and an anti-CTLA-4 antibody. Additionally, the patent describes a method for identifying suitable subjects for this treatment by measuring the TMB status of a biological sample.
Career Highlights
Joseph Szustakowski is associated with Bristol-Myers Squibb Company, where he continues to advance research in oncology. His work is pivotal in developing targeted therapies that can significantly improve patient outcomes in cancer treatment.
Collaborations
Joseph has collaborated with esteemed colleagues such as Prabhu Seshaiyer Bhagavatheeswaran and Nicholas Allan John Botwood. These collaborations enhance the research and development efforts in the field of cancer therapies.
Conclusion
Joseph Daniel Szustakowski's innovative contributions to tumor treatment exemplify the impact of targeted therapies in oncology. His work not only advances scientific understanding but also holds the potential to improve the lives of many patients battling cancer.